Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion

Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence tha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes technology & therapeutics 2021-10, Vol.23 (10), p.715-725
Hauptverfasser: Aleppo, Grazia, Parkin, Christopher G, Carlson, Anders L, Galindo, Rodolfo J, Kruger, Davida F, Levy, Carol J, Umpierrez, Guillermo E, Forlenza, Gregory P, McGill, Janet B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 725
container_issue 10
container_start_page 715
container_title Diabetes technology & therapeutics
container_volume 23
creator Aleppo, Grazia
Parkin, Christopher G
Carlson, Anders L
Galindo, Rodolfo J
Kruger, Davida F
Levy, Carol J
Umpierrez, Guillermo E
Forlenza, Gregory P
McGill, Janet B
description Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.
doi_str_mv 10.1089/dia.2021.0196
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8573795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2579789941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-48df7b40df4ae58b80ce4e8a87e5878bcab91200d2d59e3b788f9027a0fb83ab3</originalsourceid><addsrcrecordid>eNpdkUuPFCEUhYnROA9dujUkbtxUC0XRgAuTscdHJ21czLgmQN2aYVINI48xLv3nUulxoq64F76cew8HoReUrCiR6s3ozaonPV0RqtaP0DHlXHSSK_Z4qXvSKcrXR-gk5xtCiGA9fYqO2ECEWIvhGP3axVywD_gymZBnU3wMb_EZPvfZxRDAFfweyg-AgMs14AvnITjAJoz4C4zemQR4E-8gmatWJF8geYOnmNptKD7UWDO-qNbVYgIszTbkOreB2zDV3KY9Q08mM2d4fn-eom8fP1xuPne7r5-2m7Nd5wbKSzfIcRJ2IOM0GODSSuJgAGmkaJ2Q1hmraE_I2I9cAbNCykmRXhgyWcmMZafo3UH3tto9jA5CSWbWt8nvTfqpo_H635fgr_VVvNOSCyYUbwKv7wVS_F4hF71vnwTzfDCme87WklDGZENf_YfexJpCs9cooYRUaqCN6g6USzHnBNPDMpToJVzdwtVLuHoJt_Ev_3bwQP9Jk_0Gd5-iww</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2579789941</pqid></control><display><type>article</type><title>Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Aleppo, Grazia ; Parkin, Christopher G ; Carlson, Anders L ; Galindo, Rodolfo J ; Kruger, Davida F ; Levy, Carol J ; Umpierrez, Guillermo E ; Forlenza, Gregory P ; McGill, Janet B</creator><creatorcontrib>Aleppo, Grazia ; Parkin, Christopher G ; Carlson, Anders L ; Galindo, Rodolfo J ; Kruger, Davida F ; Levy, Carol J ; Umpierrez, Guillermo E ; Forlenza, Gregory P ; McGill, Janet B</creatorcontrib><description>Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare &amp; Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.</description><identifier>ISSN: 1520-9156</identifier><identifier>EISSN: 1557-8593</identifier><identifier>DOI: 10.1089/dia.2021.0196</identifier><identifier>PMID: 34077674</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Aged ; Diabetes ; Diabetes Mellitus, Type 2 - drug therapy ; Drug delivery systems ; Glucose monitoring ; Humans ; Hypoglycemic Agents - therapeutic use ; Insulin ; Insulin - therapeutic use ; Insulin Infusion Systems ; Insurance coverage ; Medicare ; Sensors ; United States</subject><ispartof>Diabetes technology &amp; therapeutics, 2021-10, Vol.23 (10), p.715-725</ispartof><rights>Copyright Mary Ann Liebert, Inc. Oct 2021</rights><rights>Grazia Aleppo, et al., 2021; Published by Mary Ann Liebert, Inc. 2021 Grazia Aleppo, et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-48df7b40df4ae58b80ce4e8a87e5878bcab91200d2d59e3b788f9027a0fb83ab3</citedby><cites>FETCH-LOGICAL-c415t-48df7b40df4ae58b80ce4e8a87e5878bcab91200d2d59e3b788f9027a0fb83ab3</cites><orcidid>0000-0001-6838-5355 ; 0000-0002-9295-3225 ; 0000-0003-3607-9788 ; 0000-0002-6228-6521</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34077674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aleppo, Grazia</creatorcontrib><creatorcontrib>Parkin, Christopher G</creatorcontrib><creatorcontrib>Carlson, Anders L</creatorcontrib><creatorcontrib>Galindo, Rodolfo J</creatorcontrib><creatorcontrib>Kruger, Davida F</creatorcontrib><creatorcontrib>Levy, Carol J</creatorcontrib><creatorcontrib>Umpierrez, Guillermo E</creatorcontrib><creatorcontrib>Forlenza, Gregory P</creatorcontrib><creatorcontrib>McGill, Janet B</creatorcontrib><title>Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion</title><title>Diabetes technology &amp; therapeutics</title><addtitle>Diabetes Technol Ther</addtitle><description>Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare &amp; Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.</description><subject>Aged</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Drug delivery systems</subject><subject>Glucose monitoring</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin</subject><subject>Insulin - therapeutic use</subject><subject>Insulin Infusion Systems</subject><subject>Insurance coverage</subject><subject>Medicare</subject><subject>Sensors</subject><subject>United States</subject><issn>1520-9156</issn><issn>1557-8593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUuPFCEUhYnROA9dujUkbtxUC0XRgAuTscdHJ21czLgmQN2aYVINI48xLv3nUulxoq64F76cew8HoReUrCiR6s3ozaonPV0RqtaP0DHlXHSSK_Z4qXvSKcrXR-gk5xtCiGA9fYqO2ECEWIvhGP3axVywD_gymZBnU3wMb_EZPvfZxRDAFfweyg-AgMs14AvnITjAJoz4C4zemQR4E-8gmatWJF8geYOnmNptKD7UWDO-qNbVYgIszTbkOreB2zDV3KY9Q08mM2d4fn-eom8fP1xuPne7r5-2m7Nd5wbKSzfIcRJ2IOM0GODSSuJgAGmkaJ2Q1hmraE_I2I9cAbNCykmRXhgyWcmMZafo3UH3tto9jA5CSWbWt8nvTfqpo_H635fgr_VVvNOSCyYUbwKv7wVS_F4hF71vnwTzfDCme87WklDGZENf_YfexJpCs9cooYRUaqCN6g6USzHnBNPDMpToJVzdwtVLuHoJt_Ev_3bwQP9Jk_0Gd5-iww</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Aleppo, Grazia</creator><creator>Parkin, Christopher G</creator><creator>Carlson, Anders L</creator><creator>Galindo, Rodolfo J</creator><creator>Kruger, Davida F</creator><creator>Levy, Carol J</creator><creator>Umpierrez, Guillermo E</creator><creator>Forlenza, Gregory P</creator><creator>McGill, Janet B</creator><general>Mary Ann Liebert, Inc</general><general>Mary Ann Liebert, Inc., publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6838-5355</orcidid><orcidid>https://orcid.org/0000-0002-9295-3225</orcidid><orcidid>https://orcid.org/0000-0003-3607-9788</orcidid><orcidid>https://orcid.org/0000-0002-6228-6521</orcidid></search><sort><creationdate>20211001</creationdate><title>Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion</title><author>Aleppo, Grazia ; Parkin, Christopher G ; Carlson, Anders L ; Galindo, Rodolfo J ; Kruger, Davida F ; Levy, Carol J ; Umpierrez, Guillermo E ; Forlenza, Gregory P ; McGill, Janet B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-48df7b40df4ae58b80ce4e8a87e5878bcab91200d2d59e3b788f9027a0fb83ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Drug delivery systems</topic><topic>Glucose monitoring</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin</topic><topic>Insulin - therapeutic use</topic><topic>Insulin Infusion Systems</topic><topic>Insurance coverage</topic><topic>Medicare</topic><topic>Sensors</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aleppo, Grazia</creatorcontrib><creatorcontrib>Parkin, Christopher G</creatorcontrib><creatorcontrib>Carlson, Anders L</creatorcontrib><creatorcontrib>Galindo, Rodolfo J</creatorcontrib><creatorcontrib>Kruger, Davida F</creatorcontrib><creatorcontrib>Levy, Carol J</creatorcontrib><creatorcontrib>Umpierrez, Guillermo E</creatorcontrib><creatorcontrib>Forlenza, Gregory P</creatorcontrib><creatorcontrib>McGill, Janet B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes technology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aleppo, Grazia</au><au>Parkin, Christopher G</au><au>Carlson, Anders L</au><au>Galindo, Rodolfo J</au><au>Kruger, Davida F</au><au>Levy, Carol J</au><au>Umpierrez, Guillermo E</au><au>Forlenza, Gregory P</au><au>McGill, Janet B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion</atitle><jtitle>Diabetes technology &amp; therapeutics</jtitle><addtitle>Diabetes Technol Ther</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>23</volume><issue>10</issue><spage>715</spage><epage>725</epage><pages>715-725</pages><issn>1520-9156</issn><eissn>1557-8593</eissn><abstract>Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare &amp; Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>34077674</pmid><doi>10.1089/dia.2021.0196</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6838-5355</orcidid><orcidid>https://orcid.org/0000-0002-9295-3225</orcidid><orcidid>https://orcid.org/0000-0003-3607-9788</orcidid><orcidid>https://orcid.org/0000-0002-6228-6521</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1520-9156
ispartof Diabetes technology & therapeutics, 2021-10, Vol.23 (10), p.715-725
issn 1520-9156
1557-8593
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8573795
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Diabetes
Diabetes Mellitus, Type 2 - drug therapy
Drug delivery systems
Glucose monitoring
Humans
Hypoglycemic Agents - therapeutic use
Insulin
Insulin - therapeutic use
Insulin Infusion Systems
Insurance coverage
Medicare
Sensors
United States
title Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-17T00%3A27%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lost%20in%20Translation:%20A%20Disconnect%20Between%20the%20Science%20and%20Medicare%20Coverage%20Criteria%20for%20Continuous%20Subcutaneous%20Insulin%20Infusion&rft.jtitle=Diabetes%20technology%20&%20therapeutics&rft.au=Aleppo,%20Grazia&rft.date=2021-10-01&rft.volume=23&rft.issue=10&rft.spage=715&rft.epage=725&rft.pages=715-725&rft.issn=1520-9156&rft.eissn=1557-8593&rft_id=info:doi/10.1089/dia.2021.0196&rft_dat=%3Cproquest_pubme%3E2579789941%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2579789941&rft_id=info:pmid/34077674&rfr_iscdi=true